1 citations
,
January 2004 in “Linchuang pifuke zazhi” This study found that topical cyclosporin-A may lead to moderate recovery in patients with severe or refractory alopecia areata, particularly in focal type cases.
August 2025 in “International Journal of Research in Ayurveda and Pharmacy” In this case study, a 35-year-old woman with persistent hair loss saw noticeable improvements after five weeks of Jalaukavacharana (Leech Therapy) and supportive Ayurvedic treatment, suggesting potential benefits of this approach for hair loss conditions.
11 citations
,
January 2009 in “Indian journal of dermatology, venereology, and leprology” This review discusses the characteristics, geography, and treatment challenges of dermatitis cruris pustulosa et atrophicans in men, emphasizing the need for further research on its etiology and management; it presents no new clinical findings.
This study reports that a combination of upadacitinib and oral minoxidil resulted in complete hair regrowth in a 20-year-old with alopecia universalis, Crohn's disease, and atopic dermatitis.
November 2022 in “CARDIOMETRY” This article discusses the potential benefits of GcMAF and oral MAF, developed by "Saisei Mirai", for cancer and other conditions, but reports no new clinical results.
June 2023 in “Dermatology and therapy” This study found that most dermatologists in the Middle East manage mild to severe alopecia areata primarily with potent topical corticosteroids and identified long-term disease control and improved efficacy as key unmet needs.
1 citations
,
August 2021 in “Journal of The American Academy of Dermatology” In this study, baricitinib treatment led to significant regrowth of scalp, eyebrow, and eyelash hair in alopecia areata patients compared to placebo, with higher effectiveness seen at the 4-mg dose.
3 citations
,
August 2019 in “Medika Tadulako: Jurnal Ilmiah Kedokteran Fakultas Kedokteran dan Ilmu Kesehatan” In this study on New Zealand white rabbits, the researchers reported that a hair tonic formula combining bitter melon leaf and carrot extracts resulted in optimal hair growth, particularly at a 3:1 ratio and a concentration of 3%, without causing irritation.
August 2024 in “Indian Dermatology Online Journal” In this retrospective study, researchers described the dermoscopic features of dermatitis cruris pustulosa et atrophicans in 30 patients, finding that follicular-based pustules and other specific features were predominant, with male patients being more affected and primarily involving the lower extremities.
4 citations
,
April 2024 in “Animals” This study reported allergic dermatitis in Brazilian donkeys linked to Culicoides insect bites, characterized by severe itching and skin lesions. The potential treatment with copaiba oil and multivitamin emulsion was explored, revealing its promise for managing this condition.
7 citations
,
August 2024 in “Clinical and Experimental Dermatology” In this retrospective study conducted at a trichology clinic, the off-label use of upadacitinib for at least 24 weeks was found to have a promising efficacy and safety profile for treating severe alopecia areata in adolescents.
November 2020 in “Zenodo (CERN European Organization for Nuclear Research)”
5 citations
,
January 2022 in “Journal of Clinical Medicine” This study observed that videodermoscopic assessments of dermatomyositis patients revealed specific vascular and pigmentary features, suggesting it may be useful for preliminary diagnosis.
September 2021 in “Journal of the Dermatology Nurses' Association” This abstract discusses the 2021 virtual Dermatology Nurses' Association Convention, outlining key dermatological insights shared, but it presents no new research findings or clinical results.
September 2023 in “Cumhuriyet science journal” This study investigated the antioxidant capacities of essential oils from myrtle and orange commonly used in the Adana region and found that myrtle essential oil exhibited a higher antioxidant activity than orange essential oil when tested with the DPPH assay.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers observed complete hair regrowth and improved quality-of-life in a 7-year-old boy with alopecia areata after a 15-week protocol involving Yoga Prana Vidya healing, suggesting its potential as an alternative treatment.
June 2025 in “Formosa Journal of Sustainable Research” In this study, the NADES extract of mangkokan leaves (Polyscias scutellaria) demonstrated antibacterial activity against Escherichia coli and Staphylococcus aureus, with a total flavonoid content measured at 4.944 mgEQ/gSimplisia using the disc diffusion method.
4 citations
,
February 2024 in “Anais Brasileiros de Dermatologia”
July 2025 in “Journal of the European Academy of Dermatology and Venereology” In this study, experts propose a diagnostic and treatment guideline for folliculitis decalvans, emphasizing the role of trichoscopy and introducing a therapeutic algorithm tailored to disease activity, which is significant for clinical management given the lack of specific clinical trials.
February 2026 in “Journal of Drugs in Dermatology” This review discusses the efficacy, safety, and practical aspects of using Janus kinase inhibitors—baricitinib, ritlecitinib, and deuruxolitinib—as treatments for severe alopecia areata in an advanced practice provider context, without reporting specific study results.
November 2025 in “Frontiers in Pharmacology” In this study, XZYFD, a Traditional Chinese Medicine formulation, was found to improve androgenetic alopecia in a testosterone-induced mouse model by promoting hair regrowth, restoring follicular morphology, and modulating androgen metabolism, MAPK signaling, and lipid metabolism pathways, suggesting potential benefits for patients with metabolic dysfunction.
July 2024 in “Jurnal PKM Manajemen Bisnis” This article describes community efforts to increase awareness and effective utilization of guava plant resources in Pamulang, aiming to improve local economic welfare through better cultivation practices and innovative processing of guava for health benefits.
August 2023 in “Journal of Investigative Dermatology” In this meta-analysis, researchers found that oral dutasteride may stabilize or improve frontal fibrosing alopecia in patients, but results varied widely, and further controlled studies are needed to confirm its effectiveness as a treatment option.
March 2026 in “Clinical Cosmetic and Investigational Dermatology” In this case study, treatment with the selective JAK1 inhibitor upadacitinib significantly improved symptoms in a patient with refractory alopecia areata, vitiligo, ankylosing spondylitis, and allergic asthma-nasal syndrome, though a transient liver function abnormality was noted.
2 citations
,
April 2019 in “Dermatologic Therapy” A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” This abstract introduces baricitinib as an approved treatment for adults with severe alopecia areata in the US, Europe, and Japan, but does not report any specific study results or findings.
13 citations
,
January 2010 in “Immunopharmacology and immunotoxicology” This study found that increased Bcl-2 protein expression after DPCP treatment was associated with hair regrowth in alopecia areata patients, suggesting its role in inhibiting apoptosis.
1 citations
,
January 2018
172 citations
,
December 2004 in “Journal of The American Academy of Dermatology” In this study, demodicoses were found to be relatively common among immunocompetent patients, with a notable overlap with papulopustular rosacea.
24 citations
,
June 1999 in “Mechanisms of Development” This study found that ornithine decarboxylase expression is linked to cell proliferation and differentiation in hair follicle development and growth.